Source: Annual Congress 2011 - COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Areias, S. Carreira, M. Anciães, P. Pinto, C. Bárbara (Lisboa, Faro, Portugal). Comorbidities in stage IV COPD patients. Eur Respir J 2011; 38: Suppl. 55, 259

Member's Comments

No comment yet.

Related content which might interest you: Co-morbidity and use of medicines during the terminal stage of life in patients with COPD Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006 Impact of symptomatology in patients with GOLD stage I COPD Source: Annual Congress 2010 - COPD: symptoms and staging Year: 2010 Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006 Comorbidities in COPD patients are not associated to higher disease severity Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003 The severity of anxiety in COPD patients (pts) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Patients at risk for COPD compared to patients diagnosed with COPD Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Care-continuity for COPD patients Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences Year: 2012 COPD patients Source: Eur Respir Monogr 2021; 90: 154-164 Year: 2021 Long-term treatment with clarithromycin of stage II COPD patients with frequent exacerbations Source: Annual Congress 2008 - Management of COPD Year: 2008 Comorbidities in COPD Source: Eur Respir J 2009; 34: 1497-1498 Year: 2009 Comorbidities of COPD Source: Eur Respir Rev 2013; 22: 454-475 Year: 2013 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 The influence of roflumilast on the IV-type collagen level in patients with III stage COPD Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012